Browse by category

Laekna Therapeutics has entered a clinical collaboration with Eli Lilly to accelerate the development of LAE102, a novel Activin Receptor...

More than half of US adults, an estimated that 137 million people, are eligible for semagludtide for weight loss, diabetes management, or...

Bariatric and metabolic surgery (BMS) is largely safe and effective for patients who are living with severe obesity, according to a team...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be associated with shrinking the human heart and other muscles, according to a...

Massachusetts Institute of Technology (MIT) and Novo Nordisk researchers have developed an ingestible capsule that releases a burst of...

Researchers at NYU Tandon School of Engineering have utilised a probabilistic physiological modelling approach to investigate the pulse...

Results from part 1 of the ongoing Phase 3 ESSENCE trial - evaluating the effect of once-weekly subcutaneous semaglutide 2.4mg on liver...

Epitomee Medical has reported that outcomes from the RESET study have revealed the total body weight for patients who received the...

GT Metabolic Solutions has completed the first magnetic compression anastomosis cases in the US using the MagDI System, the procedures...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...